is iv glutathione fda approved Injections: Benefits, Dosage, and Costs FDA: No IV glutathione product
Description
GHK-Cu (10 g/g) prevents LPS-induced decreases in lung superoxide dismutase (SOD) activity and glutathione (GSH) levels and reduces LPS-induced increases in the number of cells and the level of total protein in bronchoalveolar lavage fluid (BALF) in a mouse model of acute lung injury.Formal Name: [glycyl-kappaN-L-histidyl-kappaN,kappaN3-L-lysinato(2-)]-copper, monoacetate

[PubMed] [Google Scholar] 9.Paus R., Cotsarelis G
Nutr Metabolism
Animal Model Evidence The systemic evidence base is entirely preclinical: Pulmonary fibrosis (mouse model): Intraperitoneal GHK-Cu at 0.2-20 micrograms/g/day protected against bleomycin-induced lung fibrosis by inhibiting TGF-beta1/Smad signaling and reducing oxidative stress (PMID 31809714)

Menopause-supportive peptides often include GH secretagogues for these reasons
Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, et al